Cat. #151348
Anti-CALLA [SS2/36] mAb
Cat. #: 151348
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: Common Acute Lymphocytic Leukaemia Antigen (CALLA, CD10)
Class: Monoclonal
Application: FACS ; IHC ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Jacqueline Cordell
Institute: University of Oxford
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CALLA [SS2/36] mAb
- Clone: SS2/36
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; WB
- Description: SS2/36 is a marker for Acute Lymphocytic Luekaemia (ALL).
- Immunogen: Common acute lymphoblastic leukaemia cells
- Isotype: IgG1
- Myeloma used: P3/NS1/1-Ag4.1
Target Details
- Target: Common Acute Lymphocytic Leukaemia Antigen (CALLA, CD10)
- Target background: CALLA is expressed on B- and T- cell precursors, bone marrow stromal cells, lymphoblastic, Burkitt's, and follicular germinal center lymphomas, and on cells from patients with chronic myelocytic leukemia (CML). CALLA is a cell surface enzyme that inactivates a variety of peptides. CALLA is widely used for identification of "common" type Acute Lymphocytic Leukaemia (ALL).
Applications
- Application: FACS ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Majdic O, Sugita K, Stockinger H, Skrobal A, Knapp W (1987) Comparative evaluation of CD10 antibodies. In McMichael AJ, et al (eds) Leucocyte Typing III, Oxford University Press, Oxford, New York and Tokyo, p 488-9.
